Iqbal Kinza, Hasanain Muhammad, Rathore Sawai Singh, Iqbal Ayman, Kazmi Syeda Kanza, Yasmin Farah, Koritala Thoyaja, Thongprayoon Charat, Surani Salim
Department of Internal Medicine, Dow University of Health Sciences, Karachi, Pakistan.
Department of Internal Medicine, Dr. Sampurnanand Medical College, Jodhpur, Rajasthan, India.
Front Med (Lausanne). 2022 Nov 4;9:1038315. doi: 10.3389/fmed.2022.1038315. eCollection 2022.
Early hospital readmission (EHR) within 30 days after kidney transplantation is a significant quality indicator of transplant centers and patient care. This meta-analysis aims to evaluate the incidence, predictors, and outcomes of EHR after kidney transplantation.
We comprehensively searched the databases, including PubMed, Cochrane CENTRAL, and Embase, from inception until December 2021 to identify studies that assessed incidence, risk factors, and outcome of EHR. The outcomes included death-censored graft failure and mortality. Data from each study were combined using the random effect to calculate the pooled incidence, mean difference (MD), odds ratio (OR), and hazard ratio (HR) with 95% confidence interval (CI).
A total of 17 studies were included. The pooled EHR incidence after kidney transplant was 24.4% (95% CI 21.7-27.3). Meta-analysis showed that recipient characteristics, including older recipient age (MD 2.05; 95% CI 0.90-3.20), Black race (OR 1.31; 95% CI 1.11, 1.55), diabetes (OR 1.32; 95% CI 1.22-1.43), and longer dialysis duration (MD 0.85; 95% CI 0.41, 1.29), donor characteristics, including older donor age (MD 2.02; 95% CI 0.93-3.11), and transplant characteristics, including delayed graft function (OR 1.75; 95% CI 1.42-2.16) and longer length of hospital stay during transplantation (MD 1.93; 95% CI 0.59-3.27), were significantly associated with the increased risk of EHR. EHR was significantly associated with the increased risk of death-censored graft failure (HR 1.70; 95% CI 1.43-2.02) and mortality (HR 1.46; 95% CI 1.27-1.67) within the first year after transplantation.
Almost one-fourth of kidney transplant recipients had EHR within 30 days after transplant, and they had worse post-transplant outcomes. Several risk factors for EHR were identified. This calls for future research to develop and implement for management strategies to reduce EHR in high-risk patients.
肾移植后30天内的早期医院再入院(EHR)是移植中心和患者护理的一项重要质量指标。本荟萃分析旨在评估肾移植后EHR的发生率、预测因素和结局。
我们全面检索了包括PubMed、Cochrane CENTRAL和Embase在内的数据库,从数据库建立至2021年12月,以识别评估EHR发生率、风险因素和结局的研究。结局包括死亡删失的移植物失功和死亡率。使用随机效应合并每项研究的数据,以计算合并发生率、平均差(MD)、比值比(OR)和风险比(HR)以及95%置信区间(CI)。
共纳入17项研究。肾移植后EHR的合并发生率为24.4%(95%CI 21.7 - 27.3)。荟萃分析表明,受者特征,包括受者年龄较大(MD 2.05;95%CI 0.90 - 3.20)、黑人种族(OR 1.31;95%CI 1.11,1.55)、糖尿病(OR 1.32;95%CI 1.22 - 1.43)和透析时间较长(MD 0.85;95%CI 0.41,1.29),供者特征,包括供者年龄较大(MD 2.02;95%CI 0.93 - 3.11),以及移植特征,包括移植肾功能延迟(OR 1.75;95%CI 1.42 - 2.16)和移植期间住院时间较长(MD 1.93;95%CI 0.59 - 3.27),均与EHR风险增加显著相关。EHR与移植后第一年内死亡删失的移植物失功风险增加(HR 1.70;95%CI 1.43 - 2.02)和死亡率增加(HR 1.46;95%CI 1.27 - 1.67)显著相关。
近四分之一的肾移植受者在移植后30天内发生EHR,且他们的移植后结局较差。确定了EHR的几个风险因素。这就需要未来开展研究以制定和实施管理策略,以降低高危患者的EHR。